You are browsing the archive for -.

Castlight Appoints Driscoll as President

Posted on: May 16, 2012 by Angela SormaniNo Comments »

Castlight Health, a provider of health care transparency solutions for employers and payers, has appointed John Driscoll as president. Castlight Health is headquartered in San Francisco and backed by investors including Allen & Company, Cleveland Clinic, Maverick Capital, Morgan Stanley Investment Management, Oak Investment Partners, Redmile Group, T. Rowe Price, U.S. Venture Partners, Venrock, Wellcome [...]

Cloud-Based Security Provider Appthority Raises $6.25M

Posted on: May 2, 2012 by Alastair GoldfisherNo Comments »

Cloud-based security provider Appthority has raised a $6.25 million Series A round led by Venrock and U.S. Venture Partners. The company helps the enterprise identify and manage risks hidden in mobile apps, a growing concern as more employees bring their own tablets and smartphones to work. As part of the deal, Ray Rothrock, a partner [...]

NVCA Installs Rothrock as Chairman for Next Year

Posted on: April 25, 2012 by Alastair GoldfisherNo Comments »

Venrock Partner Ray Rothrock assumes the chairman role of the NVCA, as the organization basks in the glow of the JOBS Act.

Bizo Inks $10M

Posted on: April 2, 2012 by Staff ReporterNo Comments »

Business audience marketing startup Bizo has raised $10 million in Series B financing. Crosslink Capital led the round, with participation from return backers Bessemer Venture Partners and Venrock. The funding will help Bizo expand its sales and marketing efforts. PRESS RELEASE Bizo, the global leader in business audience marketing, today announced that it has closed [...]

Mevion Medical Systems Attracts More Funds

Posted on: January 25, 2012 by Angela SormaniNo Comments »

Mevion Medical Systems has closed a $45 million investment from ProQuest Investments. Existing investors Caxton Heath Life Sciences, Venrock and CHL Medical Partners also participated. Founded in 2004, Mevion is a privately held company headquartered in the Boston metropolitan area with international offices in the United Kingdom and Japan. PRESS RELEASE Mevion Medical Systems announced [...]

PowerVision Completes Funding Round

Posted on: January 24, 2012 by Angela SormaniNo Comments »

PowerVision, a private company developing an accommodating intraocular lens, had added Johnson & Johnson Development Corporation to its list of investors in a recent closing of its Series C financing. Current investors, Venrock, Advanced Technology Ventures, and Frazier Healthcare Ventures, also participated in the round. The closing brings PowerVision’s Series C financing round to a [...]

Mayfield and Venrock See Quick Exit from Redbeacon

Posted on: January 20, 2012 by Lawrence J. AragonNo Comments »

Just 17 months after they invested, Mayfield Fund and Venrock Associates have exited Redbeacon, an online home services site acquired by Home Depot for an undisclosed amount. Redbeacon announced the sale on its blog today. Mayfield, Venrock and an undisclosed venture firm invested $7.4 million in the company in August 2010, according to Thomson Reuters [...]

Aria Diagnostics Seals $52.7M Series C

Posted on: January 9, 2012 by Clancy NolanNo Comments »

Molecular diagnostics company Aria Diagnostics has secured $52.7 million in Series C financing, the company announced Monday. Investors include Meritech Capital Partners, Venrock and Domain Associates. The company is developing cell-free DNA analysis technology for prenatal tests. The company is based in San Jose, Calif.

Acceleron Pharma Inks $30M

Posted on: December 23, 2011 by Clancy NolanNo Comments »

Cambridge, Mass.-based Acceleron Pharma Inc. has raised $30 million in financing. The company said that strategic partner Celgene contributed to the round, along with “all other existing investors.” Acceleron has raised capital from Advanced Technology Ventures, Alkermes, Avalon Ventures, Bessemer Ventures, Celgene, Flagship Ventures, MPM BioEquities, OrbiMed Advisors, Polaris Ventures, QVT Financial, Sutter Hill Ventures and Venrock. The new funds will be used to expand the company’s clinical stage pipeline.

Cerulean Pharma Closes Series D

Posted on: December 15, 2011 by Angela SormaniNo Comments »

Cerulean Pharma, a developer of nanopharmaceuticals, has closed a $15 million Series D financing with participation from new investor, CVF, an affiliate of Henry Crown and Company of Chicago, Illinois, as well as full participation from all other existing investors, including Polaris Venture Partners, Venrock, Lilly Ventures, Lux Capital, and Bessemer Venture Partners. Cerulean’s offices [...]